23andMe Board Sees Mass Resignation of Independent Directors Over Strategic Rift
The entire slate of seven independent directors at 23andMe has stepped down over differences with CEO Anne Wojcicki regarding the strategic direction of the company. This significant move underscores a deeper clash about the future of the DNA testing firm amid its plummeting stock value and Wojcicki's bid to take the company private.
0